Delivery Order SPE2DB22D3009-SPE2DB25FBB75
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,183.01 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day contraceptive patches (3-count package). This competitively awarded, firm fixed-price delivery order was issued on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract does not carry a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with performance...
- The Defense Logistics Agency awarded a delivery order valued at $1,428.13 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack units). This competitively awarded, non-set-aside delivery order reflects firm fixed pricing and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.30 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Xulane 150-35 microgram/day contraceptive patches (3-pack). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 5, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day contraceptive patches (three-count unit) on August 5, 2025. This firm fixed price, non-set-aside delivery order is positioned for ultimate completion by August 6, 2025, with performance executed from the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,163.04 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count units) under a firm fixed price contract type. This non-set-aside award was executed on August 12, 2025, with an ultimate completion date of August 13, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,691.42 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count packaging). This is a firm fixed-price, non-set-aside contract with a completion date of August 8, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to the vendor's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $2,494.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (quantity: 3 units) on July 25, 2025, with completion targeted for July 28, 2025. This is a non-set-aside competitive award executed as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.57 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-pack units). This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of August 11, 2025. The delivery location is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,169.97 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Xulane 150-35 mcg/day contraceptive patches (3-count units). The contract is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and represents a non-set-aside competitive award. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,179.78 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child contract, this delivery order falls under AmerisourceBergen's larger...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBB75Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,787.52 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day contraceptive patches (3-count units) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order was awarded without set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location in the same municipality. The award represents a continuation of the company's role as a critical supplier to federal medical procurement systems supporting military and veteran healthcare programs. This delivery order is executed under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's status as a prime vendor reflects its demonstrated capability to meet federal procurement requirements and serve multiple federal customers, including the Defense Health Agency and U.S. Coast Guard, positioning it as a key partner in the DLA's pharmaceutical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/24/25 |